- The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017
-
Tominaga E, Kobayashi , Aoki D
- KMID: 2404023
- J Gynecol Oncol.
- 2018 Mar;29(2):e33.
- doi: 10.3802/jgo.2018.29.e33
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
-
Mikami M, Shida M, Shibata T, Katabuchi , Kigawa J, Aoki D, Yaegashi N
- KMID: 2404018
- J Gynecol Oncol.
- 2018 Mar;29(2):e23.
- doi: 10.3802/jgo.2018.29.e23
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) initiated a nation-wide training system for the education and certification for gynecologic oncologists in 2005. To assess the impact of the quality... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends of uterine carcinosarcoma in the United States
-
Matsuo K, Ross MS, Machida H, Blake EA, Roman LD
- KMID: 2404017
- J Gynecol Oncol.
- 2018 Mar;29(2):e22.
- doi: 10.3802/jgo.2018.29.e22
OBJECTIVE: Uterine carcinosarcoma (UCS) is a rare type of high-grade endometrial cancer (EC) that has been understudied with population-based statistics due to its rarity. This study examined temporal trends in... -
- CITED
-
- Close
- SHARE
-
- Close
- Major clinical research advances in gynecologic cancer in 2017
-
Suh DH, Kim M, Lee KH, Eom KY, Kjeldsen M, Mirza MR, Kim JW
- KMID: 2404021
- J Gynecol Oncol.
- 2018 Mar;29(2):e31.
- doi: 10.3802/jgo.2018.29.e31
In 2017, 10 topics were selected as major clinical research advances in gynecologic oncology. For cervical cancer, efficacy and safety analysis results of a 9-valent human papillomavirus (HPV) vaccine and... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
-
Li SS, Ma J, Wong AS
- KMID: 2404022
- J Gynecol Oncol.
- 2018 Mar;29(2):e32.
- doi: 10.3802/jgo.2018.29.e32
Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in single women with malignancy of the uterine cervix in United States
-
Machida H, Blake EA, Eckhardt S, Takiuchi T, Grubbs BH, Mikami M, Roman LD, Matsuo K
- KMID: 2404019
- J Gynecol Oncol.
- 2018 Mar;29(2):e24.
- doi: 10.3802/jgo.2018.29.e24
OBJECTIVE: To examine trends and characteristics of single women with malignancy of the uterine cervix. METHODS: This is a retrospective observational study examining the United States population-based tumor registry (the Surveillance,... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma
-
Yamazaki H, Todo Y, Shimada C, Takeshita , Minobe S, Okamoto K, Yamashiro , Kato H
- KMID: 2404014
- J Gynecol Oncol.
- 2018 Mar;29(2):e19.
- doi: 10.3802/jgo.2018.29.e19
OBJECTIVES: This study evaluated the therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma (OCCC). METHODS: We retrospectively reviewed records of 127 consecutive patients with pT1/pT2 and M0 OCCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis
-
Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa , Tsuda H, Furuya K
- KMID: 2404015
- J Gynecol Oncol.
- 2018 Mar;29(2):e20.
- doi: 10.3802/jgo.2018.29.e20
OBJECTIVE: In 2014 World Health Organization criteria, seromucinous carcinoma was defined as a new histological subtype in ovarian carcinomas, but “seromucinous carcinoma†was not defined in endometrial carcinomas. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis
-
Shim SH, Kim SN, Chae SH, Kim JE, Lee SJ
- KMID: 2404020
- J Gynecol Oncol.
- 2018 Mar;29(2):e25.
- doi: 10.3802/jgo.2018.29.e25
OBJECTIVE: Few data exist regarding adjuvant hysterectomy (AH) in locally advanced cervical cancer (LACC) patients treated with chemoradiotherapy. We investigated the effect of AH on prognosis in LACC patients, through... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
-
Paik ES, Kim TJ, Choi CH, Kim BG, Bae DS, Lee JW
- KMID: 2404013
- J Gynecol Oncol.
- 2018 Mar;29(2):e18.
- doi: 10.3802/jgo.2018.29.e18
OBJECTIVE: The aim of this investigation is to compare outcomes of patients according to the presence of cancer arising from endometriosis in ovarian clear cell carcinoma (CCC) and endometrioid carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
-
Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D
- KMID: 2404016
- J Gynecol Oncol.
- 2018 Mar;29(2):e21.
- doi: 10.3802/jgo.2018.29.e21
OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking.... -
- CITED
-
- Close
- SHARE
-
- Close
